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Abstract A nuclear magnetic resonance-based ligand
screeningstrategyutilizingaparamagneticlanthanideprobe
is presented. By ﬁxing a paramagnetic lanthanide ion to a
target protein, a pseudo-contact shift (PCS) and a paramag-
netic relaxation enhancement (PRE) can be observed for
both the target protein and its bound ligand. Based on PRE
andPCSinformation,theboundligandisthenscreenedfrom
the compound library and the structure of the ligand–protein
complex is determined. PRE is an isotropic paramagnetic
effect observed within 30 A ˚ from the lanthanide ion, and is
utilized for the ligand screening in the present study. PCS is
an anisotropic paramagnetic effect providing long-range
(*40 A ˚) distance and angular information on the observed
nuclei relative to the paramagnetic lanthanide ion, and uti-
lized for the structure determination of the ligand–protein
complex. Since a two-point anchored lanthanide-binding
peptide tag is utilized for ﬁxing the lanthanide ion to the
target protein, this screening method can be generally
appliedtonon-metal-bindingproteins.Theusefulnessofthis
strategy was demonstrated in the case of the growth factor
receptor-bound protein 2 (Grb2) Src homology 2 (SH2)
domain and its low- and high-afﬁnity ligands.
Keywords Ligand screening   Fragment-based drug
design (FBDD)   Protein-ligand structure   Lanthanide-
binding peptide tag (LBT)   Paramagnetic relaxation
enhancement (PRE)   Pseudo-contact shift (PCS)
Introduction
In fragment-based drug design (FBDD), small simple
compounds (fragments) are screened for binding to a target
protein, and the hit compounds are then optimized to
increase their afﬁnity. While the fragments found in the
FBDD screening often show weak afﬁnity (Kd*30 lM),
their afﬁnity can be improved through structure-based
optimization (Rees et al. 2004). If several fragments are
identiﬁed as binding to different sites of the target protein,
they can be linked (linking) (Shuker et al. 1996). If there is
extra space around the binding pocket, it can be ﬁlled by
modifying the initially identiﬁed fragment (growing)
(Boehm et al. 2000). In contrast to the high-throughput
screening (HTS), where the identiﬁed hits are often
hydrophobic and possess relatively higher molecular
weights, FBDD carries a higher potential to produce drug
candidates with more efﬁcient binding properties, lower
molecular mass, and higher solubility (Klages et al. 2006).
For efﬁcient FBDD, it is important to obtain structural
information on the ligand-target protein complex, even for
weakly bound ligands. Two of the most powerful tech-
niques for obtaining structural information on the ligand–
protein complex are nuclear magnetic resonance (NMR)
and X-ray crystallography. X-ray crystallography has the
ability to determine the precise three-dimensional structure
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DOI 10.1007/s10858-011-9566-5of a complex. However, the preparation of crystals of
sufﬁcient quality for structure-based ligand optimization
remains difﬁcult. Moreover, X-ray crystallography is not
free from crystallization artifacts. In contrast, NMR can
rapidly characterize molecular interactions, at atomic res-
olutions and is applicable even for weakly bound mole-
cules. It also has a lower risk of false positives.
Several NMR-based screening techniques have been
reported which are classiﬁed into two types: methods that
observe the NMR signals of small ligands (the ligand-based
approach) and those that focus on the protein NMR signals
(the protein-based approach). In a protein-based approach,
the protein NMR spectra such as
1H–
15N HSQC spectra are
measured by adding candidate ligands, thus identifying the
protein surface area that interacts with the ligands (Shuker
et al. 1996). However, this method requires a lot of protein
samples and much NMR measurement time, both of which
are an obstacle for high-throughput screening. Several
techniques have been reported for the ligand-based
approach: saturation transfer difference (STD) NMR
(Mayer and Meyer 1999; Klein et al. 1999), water-ligand
observed via gradient spectroscopy (WaterLOGSY) (Dalvit
et al. 2000, 2001, 2002; Hu et al. 2010), spin labels
attached to protein side chains as a tool to identify inter-
acting compounds (SLAPSTIC) (Jahnke et al. 2000, 2001),
inter-ligand NOE for pharmacophore mapping (INPHAR-
MA) (Sa ´nchez-Pedregal et al. 2005; Orts et al. 2009),
structural information using Overhauser effects and selec-
tive labeling (SOS)-NMR (Hajduk et al. 2004), and struc-
ture–activity relationship (SAR) by interligand nuclear
Overhauser effects (ILOEs) (Becattini and Pellecchia
2006). Since most of these techniques are based on the
1H
1D spectra of the ligands, they require less measurement
time and are free from signal assignment for the target
protein. However, despite their high-throughput capabili-
ties, these methods can’t provide structural information on
the ligand–protein complex. The exceptions are SOS-NMR
(Hajduk et al. 2004) and INPHARMA (Sa ´nchez-Pedregal
et al. 2005; Orts et al. 2009) that give structural information
on the ligand–protein complex. SOS-NMR utilizes STD
NMR experiments performed on a ligand complexed to a
series of protein samples that are deuterated except for
speciﬁc amino acid types. Analysis of the signal decaying
properties for each sample enables the structure of the
ligand–protein complex to be modeled. The INPHARMA
method exploits protein-mediated inter-ligand nuclear
Overhauser effects (NOEs) observed between two com-
petitive ligands in the presence of a target protein. If the
structure of the ligand–protein complex is known for one
ligand, the complex structure for the other ligand can be
estimated based on the intermolecular NOEs. However,
these two methods are not widely used. SOS-NMR requires
several protein samples with different deuterium labeling
patterns, which is both resource intensive and time con-
suming. In order to apply INPHARMA, the two ligands
should bind weakly to the same binding pocket, with
similar exchange rates, and the spin diffusion among pro-
tein protons should be considered. Though the structure of
the ligand–protein complex can be determined by a stan-
dard NOE-based NMR method, it is time-consuming
because almost all proton resonances and NOE signals
have to be assigned.
Here we demonstrate an NMR-based ligand screening
strategy, which can identify the ligand binding to a target
protein and also determine the complex structure, based on
the proton resonances of the ligand. In this method, a para-
magnetic lanthanide probe is utilized. Paramagnetic lantha-
nide ions ﬁxed in a protein frame induce several
paramagnetic effects in the NMR spectra of the proteins,
such as a pseudo-contact shift (PCS) and a paramagnetic
relaxation enhancement (PRE) (Otting 2008). PCS is a
chemical shift change induced by the paramagnetism of the
lanthanide ion and provides long-range (*40 A ˚) distance
and angular information on the observed nuclei. The NMR
signalsderivedfromthenucleiclosetothelanthanideionare
broadenedbecauseofparamagneticrelaxationenhancement
(PRE), which provides long-range (*30 A ˚) distance infor-
mation of the nuclei. In contrast to the conventional
approaches, most of which utilize NOE-based short-range
distance information, the paramagnetic lanthanide probe
provides long-range quantitative information and thus is
useful for the rapid structural determination of protein–
protein or protein–ligand complex structures (Saio et al.
2010; Pintacuda et al. 2007). Lanthanide probes can be
applied to any desired protein by the use of a two-point
anchored lanthanide-binding peptide tag (LBT) (Saio et al.
2009). Once the lanthanide ion is ﬁxed on the target protein,
the paramagnetic effects such as PCS and PRE can be
observed both for the target protein and the bound ligand.
Theseparamagneticeffectscanberapidlytranslatedintothe
structural information on the ligand–protein complex. This
strategy was demonstrated on the growth factor receptor-
boundprotein2(Grb2)Srchomology2(SH2)domainandits
two ligands: 4-[(10S,14S,18S)-18-(2-amino-2-oxoethyl)-
14-(1-naphthylmethyl)-8,17,20-trioxo-7,16,19-triazaspiro[5.14]
icos-11-en-10-yl]benzylphosphonicacid(macrocyclichigh-
afﬁnityinhibitor)(Gaoetal.2001)asahighafﬁnityinhibitor
and pYTN tripeptide as a low-afﬁnity ligand.
Materials and methods
Construct design
In order to ﬁx a lanthanide ion on the Grb2 SH2 domain
(60–159), a two-point anchored lanthanide-binding tag
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sequence (CYVDTNNDGAYEGDEL) (Nitz et al. 2003,
2004; Su et al. 2006, 2008) was fused to the N-terminus of
Grb2 SH2 domain and an M73C mutation was introduced:
the product is hereafter referred to as LBT-Grb2 (sup-
porting information Figure S-1A). The position of the Cys
mutation was designed based on the structure of the LBT
(1tjb.pdb, Nitz et al. 2004) and the Grb2 SH2 domain
(1x0n.pdb, Ogura et al. 2008). LBT-Grb2 was subcloned,
together with a Glutathione S-transferase (GST) tag and a
tobacco etch virus (TEV) protease cleavage site, into a
pGSTV vector (Saio et al. 2010) derived from the pET-21
plasmid (Novagen, USA).
Preparation of protein samples
LBT-Grb2 was expressed in E. coli strain BL21 (DE3)
cells. For the unlabeled sample, cells were grown in Luria–
Bertani media. For the uniformly
15N-labeled sample, cells
were grown in M9 media containing
15NH4Cl (1 g/L),
Celtone-N powder (0.2 g/L) (Cambridge Isotope Labora-
tories, USA) and unlabeled glucose (10 g/L). The uni-
formly
2H/
15N-labeled sample was prepared by culturing
cells in 100%
2H2O M9 medium containing
15NH4Cl (1 g/
L), [U–
2H] glucose (2 g/L), and Celtone-dN powder (0.2 g/
L). Cells were grown at 37Ct oA 600 of 0.8, and protein
expression was induced by the addition of isopropyl b-D-1-
thiogalactopyranoside to a ﬁnal concentration of 0.5 mM
for 16 h at 25C.
LBT-Grb2 was puriﬁed using glutathione-Sepharose 4B
resin (GE Healthcare, UK). The GST tag was removed by
incubation for 4 h at room temperature with TEV protease.
The isolated protein was then further puriﬁed by gel ﬁl-
tration chromatography on a Superdex 75 column (GE
Healthcare).
After gel ﬁltration, LBT-Grb2 was incubated with 1 mM
5,50-ditiobis(2-nitrobenzoic acid) (DTNB) for 2 h at room
temperature, which linked the N-terminal Cys of LBT and
the Cys73 on Grb2 via an intramolecular disulﬁde bond
(Saio et al. 2009, 2010). After incubation, the DTNB was
removed by dialysis.
Solid-phase synthesis of the pYTN peptide
All commercially available solvents and reagents were
used without further puriﬁcation. Tentagel S RAM (Bayer
and Rapp 1986) was purchased from Hipep Laboratories.
Fmoc amino acid derivatives were purchased from NOVA
Biochem. Fmoc-protected amino acids (Asn, Thr and Tyr
were employed as Asn(Trt), Thr(OtBut), Tyr(PO(OB-
zl)OH). All solid-phase reactions were performed manually
in a polypropylene tube equipped with a ﬁlter (LibraTube;
Hipep Laboratories).
Tentagel S RAM resin (0.035 mmol) functionalized
with a Rinkamide linker (0.25 mmol/g) was stirred with
20% piperidine/DMF in a polypropylene tube for 10 min
using a vortex mixer to remove the Fmoc group. Then the
resin was washed with dichloromethane and DMF repeat-
edly and each amino acid (0.105 mmol) was coupled with
the resin in the presence of HBTU (0.105 mmol), HOBt
(0.105 mmol), and DIEA (0.21 mmol) in DMF for 1 h at
room temperature. After washing the resin with DMF,
removal of N Fmoc protection and the coupling reaction
were repeated until the N-terminal amino acid residue was
coupled. Upon completion of the synthesis, the peptide
resin was treated with a mixture of (TFA/H2O/TIS)
95:2.5:2.5 for 2 h at room temperature. The solution was
ﬁltered and concentrated by a ﬂow of nitrogen gas, and the
crude peptide was precipitated using cold tert-butylmeth-
ylether. The crude material was puriﬁed by preparative RP-
HPLC.
The resulting crude precipitate was puriﬁed using a
preparative C-18 reversed phase column (Inertsil ODS-3
20 mm 9 250 mm) on a SHIMADZU liquid chromatog-
raphy system (HPLC) with an LC-6AD pump, at a ﬂow
rate of 5 mL/min. The column temperature was 25C, and
UV monitoring was carried out at 220 nm. Solvent A was
distilled water containing 0.1% TFA, and solvent B was
acetonitrile containing 0.1% TFA. A linear gradient of
5–15% of B over 45 min was used unless otherwise stated.
NMR spectroscopy
For the LBT-Grb2 NMR experiments, the samples were
prepared in 20 mM tris buffer (pH 7.2) with 100 mM
NaCl. For the
1H 1D NMR experiments observing the
ligand
1H signals, the samples were prepared in a deute-
rium buffer consisting of 20 mM [U-
2H] tris buffer (pD
7.2) with 100 mM NaCl in 100%
2H2O. All NMR exper-
iments were run on UNITY inova 800 or 500 MHz NMR
spectrometers (Varian, USA) at 25C. Spectra were pro-
cessed using the NMRPipe program (Delaglio et al. 1995)
and data analysis was performed with the help of the Olivia
program developed in our laboratory (Yokochi et al.
http://fermi.pharm.hokudai.ac.jp/olivia/). For the measure-
ment of PCS and PRE, the NMR spectra were acquired in
complex with 1 equivalent of lanthanide ions. Aliquots of
5m M L n C l 3 stock solution were added to the NMR
sample.
Dv-tensor calculation
Dv-tensors and the position of the lanthanide ion for LBT-
Grb2 were calculated from the PCS values and the struc-
ture of Grb2 SH2, using the Numbat program (Schmitz
et al. 2008), from (1),
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PCS ¼
1
12pr3 Dvaxð3cos2 o   1Þþ
3
2
Dvrh sin2 ocos2u
  
;
ð1Þ
where Dd
PCS is the pseudo-contact shift, r, q and u are
polar coordinates of the nucleus with respect to the prin-
cipal axes of the magnetic susceptibility tensor, and Dvax
and Dvrh are the axial and rhombic components, respec-
tively, of the anisotropic magnetic susceptibility tensor.
Conformer 1 of the family of NMR structures of Grb2 SH2
(1x0n.pdb, Ogura et al. 2008) was used for the tensor ﬁt.
Estimation of the binding afﬁnity of the pYTN
tripeptide and Grb2 SH2
The binding afﬁnity of the pYTN tripeptide and Grb2 SH2
was estimated using a
1H–
15N HSQC-based titration
experiment, where the non-labeled tripeptide was titrated
into 0.19 mM
15N-labeled Grb2 SH2. Titration curves were
obtained by plotting absolute value of chemical shift per-
turbations (Ddppm) against the concentration of the tripep-
tide. Non-linear least square ﬁtting calculations with a 1:1
binding model were performed in GraphPad Prism
(GraphPad Software, USA), using (2),
Ddppm ¼ Dd
bound
ppm
 
½P þ½ L þKd  
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð½P þ½ L þKdÞ
2   4½P ½L 
q
2½P 
;
ð2Þ
where [L] and [P] are the concentrations of the peptide
ligand and protein, respectively, and Kd is the dissociation
constant.
PCS
bound calculation
In the case of low-afﬁnity ligands indicating fast-exchange
ontheNMRtimescale,thechemicalshiftsareaverageofthe
bound and free states when the ligands and the protein are
mixed. Thus the chemical shifts of the ligand signals are
gradually changed by the titration of the protein. The
chemical shift differences between the free and bound states
(Dd
bound
ppm )ofthelow-afﬁnityligandswerecalculatedfromthe
observed chemical shift change (Ddppm), using (3),
Ddppm ¼ Dd
bound
ppm
 
½L þ½ P þKd  
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð½L þ½P þKdÞ
2   4½L ½P 
q
2½L 
;
ð3Þ
where [L] and [P] are the concentrations of the ligand
and protein, respectively, and Kd is the dissociation
constant. PCS of the bound state, PCS
bound, was
calculated by (4),
PCSbound ¼ Dd
bound
ppm ðLnÞ Dd
bound
ppm ðapoÞ; ð4Þ
where Dd
bound
ppm (Ln) and Dd
bound
ppm (apo) are the chemical shift
difference upon the binding to the protein with and without
a paramagnetic lanthanide ion, respectively.
Ligand–protein docking calculation
The high-afﬁnity inhibitor and Grb2 SH2 were docked
based on the PCS as described previously (Saio et al. 2010).
PCS-based rigid body docking was carried out using the
Xplor-NIH program (Schwieters et al. 2003, 2006) equip-
ped with PARA restraints for Xplor-NIH (Banci et al.
2004). The coordinates of Grb2 SH2 and the metal were
ﬁxed, whereas the high-afﬁnity inhibitor was treated as a
rigid body and allowed to rotate and translate. First, the
coordinates of Grb2 SH2 and the high-afﬁnity inhibitor
were both extracted from their complex structure as deter-
mined by NOE-based NMR (1x0n.pdb, Ogura et al. 2008),
and their relative orientation and position were randomized
to generate 100 starting structures. The starting positions of
the high-afﬁnity inhibitor were located within 100 A ˚ of
Grb2 SH2. The coordinates of Grb2 SH2 and the metal, on
the other hand, were ﬁxed. Next, the rigid body docking
calculation was performed based on the PCS and binding
restraints. For the PCS restraints, pseudo atoms representing
the tensor axes were introduced. The atom representing the
origin of the axis was restrained within 0.02 A ˚ of the metal,
while the coordinates of the tensor were allowed to rotate
around the origin. The position of the metal and values of
Dvax and Dvrh were ﬁxed to those determined in the Dv-
tensor calculation for Grb2 SH2 using Numbat. Though the
directions of the principal axes were also determined in the
calculation by Numbat, the directions were recalculated
during the docking calculation based on the PCSs since it
was difﬁcult to ﬁx the tensor directions in the Xplor-NIH
calculation. Note that the directions of the principal axes
determined in the docking calculation using Xplor-NIH
were almost identical to those determined by Numbat. In
PCS-based structure calculations, the symmetry of the PCS
isosurface causes several degenerated solutions that include
false structures lacking any intermolecular interaction (Saio
et al. 2010). To avoid these artifacts, a binding restraint was
added to the calculation. The binding restraint was set up as
a loose distance restraint between the two molecules, the
high-afﬁnity inhibitor and Grb2 SH2, using the r
-6 aver-
aging option, which means the two molecules locate close
to each other (Saio et al. 2010). The Xplor-NIH script for
the docking calculation is provided in Script 1 (supporting
information).
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Grb2 SH2 was almost the same as that for the high-afﬁnity
inhibitor, except that each of the three residues in the
peptide was treated as a separate rigid body. The coordi-
nates of pYTN peptide were ﬁrst extracted from the crystal
structure of Grb2 SH2 complexed with the PSpYVNVQN
peptide (Nioche et al. 2002, 1jyr.pdb), with modiﬁcation of
Val to Thr using PyMOL software (DeLano 2002). Second,
in order to generate starting coordinates, the relative ori-
entations between the three residues were randomized in
two-steps as follows. (i) Each of the three residues was
treated as a rigid body, and was randomly translated and
rotated against Grb2 SH2, generating the coordinates
where the three residues randomly and separately located.
(ii) The carbonyl carbon of pTyr and the amide nitrogen of
Thr, and the carbonyl carbon of Thr and the amide nitrogen
of Asn were tethered to each other, thus generating the
coordinates of the three-residue peptide linked by C0 and N.
These processes were repeated 100 times to generate 100
sets of the starting coordinates. Finally, the pYTN peptide
and Grb2 SH2 were docked based on PCS restrains and
binding restraints. During the docking calculation, each of
the three residues of the peptide was treated as a rigid body,
while the relative orientations between them were variable.
The Xplor-NIH script for the docking calculation is pro-
vided in Script 2 (supporting information).
Results and discussion
Screening strategy utilizing a paramagnetic lanthanide
probe
The ligand screening strategy utilizing the paramagnetic
lanthanide probe is described as follows (Fig. 1).
(A) Screening step: Ligand binding to the target protein can
be identiﬁed from compound mixture based on Gd
3?-
induced PRE. Gd
3? induces strong PRE due to long elec-
tron-spin relaxation time but does not induce PCS due to
the isotropic paramagnetic susceptibility tensor. A T1q
relaxation experiment is carried out on a mixture of ligand
candidates in the presence of the target protein containing
Gd
3?. A two-point anchored LBT enables Gd
3? to be
introduced into any target proteins (Saio et al. 2009). The
1H 1D NMR spectra with short and long spinlock periods
are measured. If any ligands bind to the target protein, the
NMR signals of the ligand are affected by PRE, which is
reﬂected by the reduction in the signal intensity at the long
spinlock period. Thus, efﬁcient ligand screening can be
achieved by T1q measurements. (B) Structural analysis:
Ligands hit in the screening step are further analyzed,
where the structure of the ligand–protein complex can be
rapidly determined based on PCSs. PCS restraints can be
readily collected by replacing the Gd
3? ion with the
paramagnetic lanthanide ions that have anisotropic mag-
netic susceptibility tensors such as Tb
3?,T m
3?, and Dy
3?.
Once anisotropic magnetic susceptibility tensor (Dv-tensor)
parameters are determined for each lanthanide ion based on
the PCSs observed for the protein, ligand PCSs can be
translated into quantitative structural information on the
complex. Since the Dv-tensor parameter determination
requires at least 8 PCSs, a sufﬁcient number of PCSs can be
collected based on the limited number of NMR signals,
such as backbone amide signals from
1H–
15N HSQC
spectra.
In this study, the above strategy was applied to Grb2
SH2 and its two ligands: 4-[(10S,14S,18S)-18-(2-amino-2-
oxoethyl)-14-(1-naphthylmethyl)-8,17,20-trioxo-7,16,19-
triazaspiro[5.14]icos-11-en-10-yl]benzylphosphonic acid
(macrocyclic high-afﬁnity inhibitor) (Gao et al. 2001)a n d
pYTN tripeptide (low-afﬁnity ligand).
A lanthanide ion was ﬁxed on a target protein using
a two-point anchored LBT
For the application of the paramagnetic lanthanide probe,
the lanthanide ion has to be rigidly ﬁxed in a protein frame.
Although some metal-binding proteins can bind lanthanide
Fig. 1 Schematic
representation of the NMR
ligand screening method
utilizing a paramagnetic
lanthanide probe
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123ions, many proteins lack metal-binding sites and require a
lanthanide-binding tag for the application of the lanthanide
probe method. In our previous work, we proposed a two-
point anchored LBT that is attached to the target protein
via N-terminal fusion and disulﬁde bond, thus holding the
lanthanide ion in a rigid position (Saio et al. 2009). In this
study we utilized this tagging method, by which a lantha-
nide ion was attached to Grb2 SH2. The LBT sequence
(CYVDTNNDGAYEGDEL) was fused to the N-terminus
of Grb2 SH2, and an M73C mutation was introduced on the
surface of Grb2 SH2. The position of the Cys mutation was
designed based on the structures of LBT (1tjb.pdb, Nitz
et al. 2004) and Grb2 SH2 (1x0n.pdb, Ogura et al. 2008),
according to the following considerations. In the LBT
crystal structure, the distance between the C
a atoms of the
N- and C-terminal residues is around 7 A ˚. We searched for
a residue about 7 A ˚ in distance from N-terminal residue
(Trp60) of Grb2 SH2, and found Met73 (supporting
information Figure S-1A). The C
a distance between Trp60
and Met73 was 9.9 A ˚. A linker sequence was introduced to
the fusion point between LBT and Grb2 SH2, in order to
avoid structural distortion and steric hindrance. The length
of the linker was optimized.
15N-labeled LBT-Grb2 con-
taining three- (HMA), four- (HMAG), or ﬁve-residue
(HMAGS) linkers were prepared and the
1H–
15N HSQC
spectra were acquired in the presence of 1 equivalent of
terbium ion. As shown in Figure S-1B (supporting infor-
mation), the construct with the three-residue linker showed
broad signals, whereas the constructs with four- and ﬁve-
residue linkers showed sharp well-dispersed single peaks.
Thus we concluded that the three-residue linker is too
short, and that the four- and ﬁve-residue linkers match the
distance requirements. The construct with the four-residue
linker, hereafter referred to as LBT-Grb2, was used for the
following experiments.
PCS observation and tensor determination
for LBT-Grb2
Pseudo-contact shift values were measured as the differ-
ence in the backbone amide proton chemical sifts; i.e., the
chemical shifts observed in complex with paramagnetic
lanthanide ions minus those observed in complex with the
diamagnetic Lu
3? ion. The backbone amide signals of
LBT-Grb2 containing Lu
3? were assigned based on the
assignments reported previously (Wang et al. 1996;
Thornton et al. 1996; Ogura et al. 2008).
1H–
15N HSQC
spectra of the
15N-labeled LBT-Grb2 were recorded in the
presence of 1 equivalent of lanthanide ions: Lu
3?,T b
3?,
Dy
3?,E r
3? and Tm
3? (Fig. 2). Since the
1H and
15No f
each amide group are spatially close, the PCS has similar
ppm values in both
1H and
15N dimensions (Saio et al.
2009, 2010). Thus, by overlaying the spectra recorded with
different lanthanide ions, the signals were aligned along a
straight line. Based on this behavior, the
1H–
15N HSQC
cross-peaks of the paramagnetic samples were readily
assigned using the assignment of the diamagnetic samples.
Finally a total of 224 PCSs were observed for amide proton
resonances of LBT-Grb2 (55, 56, 57, and 56 PCSs for
Dy
3?,T b
3?,E r
3? and Tm
3?, respectively) (Supporting
information Table S-1).
Based on the PCSs observed for the backbone amide
signals of LBT-Grb2, Dv-tensor was determined for each
lanthanide ion using the Numbat program (Schmitz et al.
2008). In the tensor calculation, tensor parameters for
Dy
3?,T b
3?,E r
3? and Tm
3? were simultaneously ﬁtted
with each lanthanide having a shared metal position
because of the isomorphous nature of the lanthanide ions
(Saio et al. 2010). The Dv-tensor parameters were well
deﬁned with the principal axes for the four lanthanides
oriented in similar directions (Table 1; Fig. 3a, supporting
information Figure S-2). The correlations between the
experimental and back-calculated values were good
(Fig. 3b–e). Thus we concluded that the lanthanide ion was
ﬁxed in the protein frame and the Dv-tensor parameters
including metal position were well determined.
Ligands bound to the target protein can be identiﬁed
based on PREs
Once the LBT is introduced to the target protein, several
paramagnetic effects can be exploited simply by changing
the lanthanide ion. First we examined PRE-based ligand
screening using Gd
3?, which induces strong PRE but
without any PCS. Jahnke et al. (2000, 2001) reported a
Fig. 2
1H–
15N HSQC spectra of
15N LBT-Grb2 in complex with
Lu
3? (gray), Dy
3? (red), Tb
3? (orange), Er
3? (green), and Tm
3?
(blue). Spectra were acquired using an 800 MHz NMR spectrometer
at 25C
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123Table 1 Dv-tensor parameters for lanthanide ions in complex with LBT-Grb2
a
Dy
3? Tb
3? Er
3? Tm
3?
Dvax
b 22.7 ± 1.3 29.2 ± 1.7 -7.7 ± 0.7 -17.5 ± 1.6
Dvrh
b 17.6 ± 0.7 16.9 ± 0.5 -7.3 ± 0.2 -17.1 ± 0.5
a
c 106 97 104 99
b
c 57 52 57 65
c
c 53 34 36 27
a Dv-tensor parameters were determined relative to the conformer 1 of the family of NMR structures of Grb2 SH2 (1x0n.pdb). Metal ion
coordinates were x =-12.9, y =-5.3, z =-4.9
b Dvax and Dvrh values are in 10
-32 (m
3) and error estimates were obtained by the Monte-Carlo protocol using 100 partial PCS data sets in which
30% of the input data were randomly deleted
c Euler angle rotations in ZYZ convention (degrees)
Fig. 3 Dv-tensor determination
for LBT-Grb2. a Orientation of
the principal axes of the Dv-
tensors of Dy
3?,T b
3?,E r
3?,
and Tm
3? in complex with
LBT-Grb2, visualized in
Sanson-Flamsteed projection.
The plots show the points where
the principal axes of the Dv-
tensor penetrate the sphere. The
convention |z|[|y|[|x| was
used to name the axes, which
occasionally caused swapping
between the z- and y-axes of the
tensors when their magnitudes
were similar. One hundred sets
of plots represent the results of
the Monte-Carlo analysis using
the 100 partial PCS data sets in
which 30% of the input data
were randomly deleted.
b–e Comparison between
experimental and back-
calculated PCSs of backbone
amide protons observed in LBT-
Grb2 in the presence of Dy
3?
(b), Tb
3? (c), Er
3? (d), and
Tm
3? (e). The ideal correlations
are indicated
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123PRE-based screening method utilizing a 2,2,6,6-tetra-
methyl-piperidine-1-oxyl (TEMPO) spin-label as a para-
magnetic center (SLAPSTIC). For the lanthanide probe-
based screening strategy, we utilized Gd
3? as a ﬁxed
paramagnetic center and carried out a T1q relaxation
experiment. A 0.2 equivalent of LBT-Grb2 containing
Gd
3? was added to a solution of the pYTN tripeptide
(840 lM) mixed with the other six compounds (840 lM
for each) as a model study and
1H spinlock 1D NMR
spectra were acquired with spinlock period of 10 or 200 ms
(Fig. 4). The signals of the pYTN tripeptide were speciﬁ-
cally attenuated in the spectra with long spinlock period.
The NMR signals of the ligand binding to the target protein
were affected by the Gd
3? PRE, which was reﬂected by the
signal decay at the long spinlock period. In contrast, the
signals derived from the compounds other than pYTN
showed no signiﬁcant signal decay. Thus the ligand bind-
ing to the target protein can be identiﬁed in the compound
mixture based on the PRE. This screening experiment
requires only two
1H spinlock 1D NMR spectra measured
on a single NMR sample, which is advantageous to rapid
screening. Although the signals of the pYTN tripeptide
were also attenuated in the experiment using LBT-Grb2
lacking Gd
3? (Fig. 4b, d), the relaxation effects were much
smaller. This means that use of Gd
3? allows a reduction in
the amount of protein used for the experiments, and also
allows more weakly bound ligands to be detected.
Structure of the ligand–protein complex is rapidly
determined based on the ligand PCSs: the case
of the low-afﬁnity ligand
The ligand identiﬁed in the above PRE-based screening is
further analyzed based on PCSs. Quantitative analysis of
the PCSs observed for the ligand enables structure deter-
mination of the ligand–protein complex, from PCS-based
ligand–protein docking calculation. To demonstrate the
PCS-based structure determination of the ligand–protein
complex, we ﬁrst carried out the analysis on the low
afﬁnity pYTN peptide (Fig. 5c) (Gay et al. 1999; Kessels
et al. 2002). Prior to the structural analysis, the binding
afﬁnity of the tripeptide and Grb2 SH2 was estimated from
an NMR titration experiment, where the non-labeled tri-
peptide was titrated into a solution of
15N-labeled Grb2
SH2. Shifts in the resonances during the titration indicated
that the binding and dissociation were fast on the NMR
timescale (supporting information Figure S-3). The disso-
ciation constant was calculated based on the signals of
A91, F95, S96, and W121 (supporting information Figure
S-4). A non-linear least square ﬁtting of the data to a 1:1
binding model yielded a dissociation constant (Kd)o f
70.4 ± 7.8 lM.
In the case of the lower afﬁnity ligands, which are often
encountered in FBDD screening, the observed PCSs are
weighted averages of the free and bound states because of
Fig. 4
1H spinlock 1D NMR
spectra of the pYTN tripeptide
in the presence of the other six
compounds including adenine,
thymine, uracil, glycine, serine,
and DMSO. The signals derived
from adenine (8.23, 8.18 ppm),
thymine (7.35 ppm) and uracil
(7.53, 7.51, 5.80, 5.78 ppm) are
observed in the selected region
of the spectra. The spectra were
acquired with a spinlock period
of 10 ms (a, b) or 200 ms (c, d).
A 0.2 eq of LBT-Grb2 with
(a, c) and without (b, d)G d
3?
were added. Asterisks indicate
the resonances derived from the
pYTN tripeptide. Spectra were
acquired using a 500 MHz
NMR spectrometer at 25C
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123the fast exchange process. In such cases, the structure of
the ligand–protein complex can be determined based on the
PCS
bound (the PCS values for the bound state), which is
obtained from titration experiments and curve ﬁtting.
1H
1D NMR spectra of the pYTN tripeptide were measured
during the titration with non-labeled LBT-Grb2. Two sets
of data were collected: one for titration with Tm
3?-bound
LBT-Grb2, and the other for titration with LBT-Grb2
lacking the lanthanide ion (apo-state). Although the signals
of the tripeptide were gradually obscured by the signals
derived from LBT-Grb2, the signal shifts could be
observed during the early stage of the titration experiment
(Fig. 5a). Chemical shift changes of the pYTN tripeptide
were plotted against the amount of LBT-Grb2 added to the
solution (Fig. 5b). The titration curves were ﬁtted using (3)
to determine the chemical shift difference between the free
and bound state of the pYTN tripeptide, as described in the
‘‘Materials and methods’’ section. The Kd value was ﬁxed
to 70.4 lM as determined by the titration experiment with
15N-labeled Grb2 SH2 and the non-labeled pYTN tripep-
tide. Chemical shift changes were determined both for
LBT-Grb2(Tm
3?) and LBT-Grb2(apo), and the differences
in these values were deﬁned as the PCSs for the bound state
(4). In addition to Tm
3?, PCSs were observed using Tb
3?
and Dy
3?, and a total of 16 PCS values were obtained for
Tm
3?,T b
3? and Dy
3? (Fig. 5c).
Pseudo-contact shift-based docking calculation was
performed for the pYTN peptide and Grb2 SH2, using the
Xplor-NIH program (Schwieters et al. 2003, 2006). Each of
the three residues in the peptide was separately treated as a
rigid body and their relative orientations were set to be
variable during the calculation (see the ‘‘Materials and
methods’’ section for details). One hundred calculations
were performed and the 10 lowest energy structures were
selected according to the two-step selection: the 20 struc-
tures were selected based on the PCS energy, then the ﬁnal
10 structures were selected based on the total energy.
The lowest energy structure and the ensemble of the 10
lowest energy structures are shown in Fig. 6a and b,
respectively. The RMSD value calculated for all atoms of
pYTN peptide was 2.96 A ˚. The structure of the pYTN
peptide roughly corresponds to that determined by X-ray
crystallography (Fig. 6c), and the correlations between the
experimental and back-calculated PCS values were good
(Fig. 6d). Although the convergence of pTyr and Thr was
reasonably good, the direction of the Asn residue was not
deﬁned: some conformers indicated Asn to be oriented in
the direction of the protein, whereas others indicated it to
be oriented in the opposite direction. This is presumably
because of the distribution of the PCS isosurface (sup-
porting information Figure S-2), on which the Asn residue
slides away. Though this ambiguity could be eliminated by
the use of the additional PCSs induced by the lanthanide
ion attached at the different positions on the protein, the
interaction between the Asn residue and Grb2 SH2 is well
implied by the present structure.
Though structural information on the ligand–protein
complex is inevitable for FBDD, it is often difﬁcult to
obtain the structural information in case of low-afﬁnity,
fast-exchanging ligands. We here demonstrated that the
structure of the low-afﬁnity ligand in complex with the
Fig. 5 Calculation of the PCSs for the bound state of the pYTN
tripeptide. a Selected region of the
1H NMR spectra of the pYTN
tripeptide, acquired during titration of LBT-Grb2 containing Tm
3?.
The spectra of the tripeptide in the presence of 0 equivalent (blue)t o
0.7 equivalent (purple) LBT-Grb2-Tm
3? are overlaid. b Chemical
shift changes of the signals of the pYTN tripeptide during titration
with increasing amounts LBT-Grb2 containing Tm
3?. c The chemical
structure of the pYTN tripeptide on which the observed PCS values
are indicated
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123target protein could be determined based on the PCSs,
based on which the binding region for the protein and the
orientation of the ligand could be estimated. The binding
position and orientation of each of the fragments, ‘‘resi-
dues’’ in this case, can also be estimated. Despite the
simpliﬁed treatment of the present fragment approach,
the PCS data of both Grb2 and the peptide can deﬁne the
structure of the peptide bound to Grb2 in a reasonable
quality.
Structure determination of the complex: the case
of the high-afﬁnity inhibitor
In order to demonstrate the PCS-based structure determi-
nation for high-afﬁnity ligands, we conducted an analysis
on the high-afﬁnity inhibitor, 4-[(10S,14S,18S)-18-(2-
amino-2- oxoethyl)-14-(1-naphthylmethyl)-8,17,20-trioxo-
7,16,19-triazaspiro[5.14]icos-11-en-10-yl]benzylphosphonic
acid (Fig. 7a) (Gao et al. 2001), in complex with LBT-
Grb2. The high-afﬁnity inhibitor strongly binds to Grb2
SH2, and their binding and dissociation are slow on the
NMR timescale (Ogura et al. 2008). Thus, the chemical
shift changes of the high afﬁnity inhibitor, upon the addi-
tion of Grb2 SH2, are equal to those between the free and
bound states.
We prepared the high-afﬁnity inhibitor in complex with
2H/
15N-labeled LBT-Grb2 and measured
1H1 DN M R
spectra in the presence and absence of the paramagnetic
lanthanide ion Tm
3?. Based on these 1D spectra, 11 Tm
3?-
induced PCSs were observed for the high-afﬁnity inhibitor
(Fig. 7b). The PCSs were further assigned with the help of
2D TOCSY experiment. In addition to Tm
3?, PCSs were
observed using Tb
3? and Dy
3?, and ﬁnally 56 PCS values
were assigned for the high-afﬁnity inhibitor (Fig. 7a).
Although PCS values are usually measured with reference
to the diamagnetic lanthanide ion, such as Lu
3?, here we
used an apo-state sample as the reference as we were
aiming for a rapid and simple experiment based on the fact
that the
1H 1D spectrum of the inhibitor in complex with
apo-state
2H/
15N-labeled LBT-Grb2 was identical to that
with Lu
3?-bound LBT-Grb2 (data not shown).
Next, PCS-based docking calculation was carried out
using the Xplor-NIH program (Schwieters et al. 2003,
2006) with a rigid body minimization protocol (Clore
2000; Tang and Clore 2006; Saio et al. 2010). For the
Fig. 6 The docking structure of
Grb2 SH2 and the pYTN
tripeptide. a The lowest energy
structure. Grb2 SH2 and the
tripeptide are represented as
ribbon and stick models,
respectively. The position of the
lanthanide ion is represented as
a yellow sphere. b Ensemble of
the 10 lowest energy structures.
Grb2 SH2 moieties are
superimposed. pTyr, Thr, and
Asn are colored blue, green, and
orange, respectively. c X-ray
crystal structure of Grb2 SH2
complexed with a
phosphorylated peptide
(PSpYVNVQN) (Nioche et al.
2002, 1jyr.pdb). The
corresponding residues of the
peptide are displayed as a stick
model. The structures were
drawn using the program
PyMOL (DeLano 2002).
d Comparison of experimental
and back-calculated PCSs of
proton signals of the low-
afﬁnity peptide (ﬁlled circles)
and backbone amide proton
signals of Grb2 SH2 (open
squares) in complex with Tm
3?.
The PCS calculation was carried
out for the lowest energy
structure of the complex
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123docking calculation, PCSs derived from Tm
3?,T b
3? and
Dy
3? were used: 125 PCSs for Grb2 SH2 and 56 PCSs for
the high-afﬁnity inhibitor. The position of the lanthanide
ion against Grb2 SH2 was ﬁxed at the position determined
by the tensor calculation using Numbat. Grb2 SH2 and the
inhibitor were treated as rigid bodies, and docked based on
the PCS restraints and binding restraints (see ‘‘Materials
and method’’ section for details). One hundred calculations
were performed and the 10 lowest energy structures were
selected according to the two-step selection procedure
described above.
The lowest energy structure is shown in Fig. 8a. The
position and orientation of the high-afﬁnity inhibitor cor-
respond well to those of the structure determined by an
NOE-based NMR method (Fig. 8c). Furthermore, the 10
lowest energy structures are well deﬁned as shown in
Fig. 8b. The RMSD value calculated for all atoms of the
high-afﬁnity inhibitor was 1.91 A ˚. It should be also noted
that the correlations between the experimental and back-
calculated PCS values were good, which supports the
compatibility of the docking structure (Fig. 8d).
Advantages against conventional methods
As shown in Figs. 6 and 8, the PCS-based structures of the
ligand–protein complexes were less precise than those
determined by X-ray crystallography or an NOE-based
conventional NMR method. However, a high-resolution
structure is not necessarily required at the early stage of
FBDD (Jahnke 2007). One of the advantages of our strat-
egy is its rapidness.
In our PCS-based strategy, no time-consuming side-
chain assignment or NOE analysis is required. Dv-tensor
parameters, required for PCS-based structure determina-
tion, can be determined based on at least 8 PCSs of the
protein: thus a limited number of signal assignments are
sufﬁcient for tensor determination. Several assignment
techniques, that are free from time-consuming, low-sensi-
tive three-dimensional NMR experiments, have been
developed: signal assignment based on the amino acid
selective labeling (Trbovic et al. 2005; Ozawa et al. 2006),
site-speciﬁc labeling of unnatural amino acids (Jones et al.
2010), site-directed mutagenesis (Religa et al. 2010), and
the lanthanide probe method (Pintacuda et al. 2004; John
et al. 2007). Although it is difﬁcult to assign all of the
resonances of the protein using the above methods, these
techniques are suitable for rapid assignments and are
applicable for even large proteins or membrane proteins.
Once the Dv-tensor is determined for the target protein,
PCSs observed for the ligand can be translated into quan-
titative structural information on the ligand–protein com-
plex. In the conventional NMR approach, it is difﬁcult to
discuss the ligand–protein complex structure based only on
limited NMR signals.
The PCS-based structure determinations of protein–
ligand complexes were previously reported for a metallo-
protein (John et al. 2006) and a non-metalloprotein with the
LBT attached via a single fusion point (Zhuang et al.
2008). Although the ligand–protein structure was precisely
determined in the case of the metalloprotein, the method
was not applicable to general proteins lacking a metal-
binding site. In case of the analysis utilizing the one-point
anchored LBT, an inter-molecular NOE restraint was
required for accurate structure determination, which would
be a disadvantage for rapid structural analysis. In this study
we determined more precise ligand–protein structures
without speciﬁc inter-molecular NOE restraints, by
exploiting the two-point anchored LBT that can hold the
lanthanide ion more rigidly (Saio et al. 2009).
Conclusion
Although the use of the lanthanide probe has been limited
to some metalloproteins, here we exploited the two-point
Fig. 7 Analysis on the high-afﬁnity inhibitor and LBT-Grb2. a The
chemical structure of the inhibitor in which the protons were labeled.
Proton signals were assigned according to the previous work (Ogura
et al. 2008). Observed PCS values are indicated. b Overlay of the
1H
1D spectra of the high-afﬁnity inhibitor complexed with
2H
15N-
labeled LBT-Grb2. The spectra measured in the presence and absence
of the paramagnetic lanthanide ion Tm
3? are shown in blue and gray,
respectively. An asterisk indicates an impurity. Spectra were acquired
using an 800 MHz NMR spectrometer at 25C
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123anchored LBT and demonstrated that a lanthanide probe-
based ligand screening method can be applied to non-
metalloproteins. Since lanthanide ions have similar
chemical properties but diverse magnetic properties, the
distinct paramagnetic effects can be utilized simply by
replacing the lanthanide ion added to the sample. Gd
3?
induces strong PRE but no PCS. Thus it is useful for
rapid identiﬁcation of the hit ligand. Paramagnetic lan-
thanide ions other than Gd
3? induce PCSs that are useful
for rapid structure determination of the ligand–protein
complex. We proposed a hybrid strategy exploiting the
advantages of both paramagnetic effects, by which the
experiments from screening to structural analysis can be
completed in a single system. The method was success-
fully applied to ligand screening and structural analysis of
a protein–ligand complex with both low- and high-afﬁnity
ligands.
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